Physician profile
Peter Ngo
NPI 1417918525
$4,224.06
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $896 · 2021: $959 · 2022: $897 · 2023: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $649.80 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $598.06 | 2019-2022 | |
| Novo Nordisk INC | $577.48 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $494.99 | 2019-2023 | Mounjaro, Jardiance, Lyumjev |
| Abbvie INC. | $267.10 | 2021-2023 | |
| Abbott Laboratories | $197.42 | 2019-2023 | Freestyle Libre |
| Amgen INC. | $196.16 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $157.54 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $138.46 | 2021-2023 | Gvoke Hypopen |
| Esperion Therapeutics, INC. | $127.08 | 2020-2022 | |
| Amryt Pharma Holdings Ltd | $100.19 | 2022-2023 | Mycapssa |
| Sanofi-Aventis U.S. LLC | $100.15 | 2020-2023 | |
| Dexcom, INC. | $85.23 | 2021-2022 | |
| Corcept Therapeutics | $82.96 | 2020-2023 | Korlym |
| Medtronic, INC. | $75.48 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $54.39 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $42.43 | 2021-2022 | |
| Ibsa Pharma INC. | $41.99 | 2020-2023 | Tirosint, Licart |
| Bayer Healthcare Pharmaceuticals INC. | $32.13 | 2022-2023 | |
| Recordati_rare_diseases_inc. | $29.38 | 2022 | |
| Ascensia Diabetes Care US INC. | $27.80 | 2019 | |
| Bigfoot Biomedical INC | $21.62 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.98 | 2020 | |
| Evoke Pharma, INC. | $19.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.51 | 2019 | |
| Aytu Biopharma, INC. | $13.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.78 | 2020 | |
| Tandem Diabetes Care, INC. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.